Stage IIIA Skin Melanoma Active Not Recruiting Phase 1 Trials for DB01611 (Hydroxychloroquine)

IndicationStatusPhase
DBCOND0029533 (Stage IIIA Skin Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01480154Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerTreatment